When we evaluated the HLA-G 14-bp Ins/Del polymorphism–cancer risk association according to source of the control, a significantly decreased risk was observed in PB controls but not in hospital-based controls; this result further verifies that the HLA-G 14-bp Ins/Del polymorphism is a potential protective factor for cancer. The gene discussed is HLA-G; the disease is cancer.